Sofocure L 90 mg,400 mg Tablet About
Presenting Sofocure L 90 mg,400 mg Tablet-an uncommon champion in the fight against chronic Hepatitis C. This best-seller is offered at a remarkable reduced price, catering to patients across the globe. Each splendid, film-coated, light yellow tablet combines Ledipasvir (90 mg) and Sofosbuvir (400 mg), approved internationally for reliable HCV therapy. Manufactured in a WHO-GMP certified facility, Sofocure L meets the highest pharmaceutical grade and assay standards. Designed for adult patients, the medicine comes in bottles within secure carton boxes, ready to ship worldwide with a convenient lead time.
Application and Therapeutic Use of Sofocure L Tablets
Sofocure L 90 mg,400 mg Tablet is administered orally, specifically targeting adults with chronic Hepatitis C infections. Its site of application is systemic, with the medication working internally to combat HCV genotypes 1, 4, 5, and 6. Used as a potent antiviral regimen, it is typically prescribed for daily use or as directed by a healthcare provider. Sofocure L is widely recognized for its efficacy in treating chronic HCV, promoting improved liver health and reducing viral loads.
Packaging Details and Shipping for Sofocure L Tablets
Each carton box of Sofocure L contains a securely packed bottle with 28 film-coated tablets, ensuring optimal protection during shipment. We offer freight solutions from major Indian FOB ports, delivering the product at the lowest price for global clients. With prompt arrival guaranteed within 1-2 weeks of order confirmation, our main domestic market remains India while extensive international exports ensure a seamless supply chain for our valued customers worldwide.
FAQ's of Sofocure L 90 mg,400 mg Tablet:
Q: How should Sofocure L 90 mg,400 mg Tablet be taken?
A: Sofocure L should be taken orally, once daily, or exactly as prescribed by your physician. Swallow the tablet whole with water and do not crush or chew it.
Q: What conditions does Sofocure L treat?
A: Sofocure L is indicated for adult patients in the treatment of chronic Hepatitis C virus (HCV) infection, specifically genotypes 1, 4, 5, or 6.
Q: When will my order for Sofocure L arrive after confirmation?
A: Once your order is confirmed, Sofocure L is dispatched with an estimated lead time of 1-2 weeks for global delivery, depending on your location and selected freight options.
Q: Where is Sofocure L manufactured and exported from?
A: Sofocure L is manufactured in a WHO-GMP certified facility in India, meeting stringent international standards, and exported worldwide through major Indian FOB ports.
Q: What are the key benefits of using Sofocure L?
A: Sofocure L offers a highly effective and convenient oral solution for chronic Hepatitis C. Its splendid efficacy and uncommon reliability have made it a champion among anti-viral agents, helping patients achieve sustained virologic response.